Loading chat...
MO SB825
Bill
Status
Introduced
1/25/2010
Primary Sponsor
Dan Clemens
Click for details
AI Summary
- Repeals existing section 338.056 and enacts new sections 338.056 and 338.058 regarding generic drug substitution and anti-epileptic drug interchange restrictions
- Allows pharmacists to substitute generic drugs for brand-name drugs if the generic costs less, unless the patient requests otherwise or the prescription specifies "Dispense as Written"
- Defines "interchange" as substituting one manufacturer's anti-epileptic drug for another's, including generic-to-brand, brand-to-generic, or generic-to-generic substitutions by different manufacturers
- Requires pharmacists to notify the patient, family members, or designees and the prescriber before interchanging anti-epileptic drug manufacturers when seizures are currently controlled on a specific drug and dosage regimen
- Exempts prescriptions dispensed to inpatients of hospitals, long-term care facilities, or mental health facilities from the anti-epileptic drug interchange restrictions
Legislative Description
Prohibits the substitution of anti-epileptic drugs under certain circumstances
Last Action
Hearing Conducted S Health, Mental Health, Seniors and Families Committee
2/16/2010
Committee Referrals
Health, Mental Health, Seniors And Families1/28/2010
Full Bill Text
No bill text available